According to the New York Times on 7/15/10, GlaxoSmithKline will settle approximately 10,000 lawsuits concerning Avandia, with each patient receiving around $46,000. GlaxoSmithKline was reportedly facing more than 13,000 lawsuits alleging that the company did not properly warn physicians and patients of the risk of heart attacks. Some analysts predicted GlaxoSmithKline could pay up to $6 billion to settle Avandia litigation, the Times reports.
GlaxoSmithKline announced it will pay a total of approximately $2.6 billion in the second quarter to settle lawsuits involving both Avandia and Paxil. The drug maker would have faced the first of the Avandia lawsuits in court in October 2010.
READ MORE AVANDIA LEGAL NEWS
The same day, when asked if they were concerned that Avandia causes heart attacks, 18 panel members voted that they were concerned, nine voted that they were not sure if Avandia could cause heart attacks and six voted that they were not concerned about the risk of heart attacks.
The advisory panel can only make recommendations to the FDA; its votes are not binding and the FDA does not have to follow its recommendations. Patients who currently take Avandia and are concerned about the medication should not stop taking the drug without first consulting with their doctor.